Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A human abuse potential study of Rexista

Trial Profile

A human abuse potential study of Rexista

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Oct 2018 According to an Intellipharmaceutics International clinical component of study has been completed.Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
    • 08 May 2018 Status changed from planning to recruiting, according to an Intellipharmaceutics media release.
    • 08 May 2018 According to an Intellipharmaceutics media release, this study is being conducted by the Altasciences Clinical Research (Montreal).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top